Search

Search Constraints

You searched for: Author/Creator Tritsmans, Luc

Search Results

1. [P2–211]: AMYLOID‐β42 (Aβ42) DIFFERENTIALLY CORRELATES WITH CSF TOTAL AND HYPERPHOSPHORYLATED TAU IN AN AMYLOID‐POSITIVE VERSUS AMYLOID‐NEGATIVE EARLY PRODROMAL AND ASYMPTOMATIC AT‐RISK FOR AD POPULATION. (1st July 2017)

2. Evaluating Potential QT Effects of JNJ‐54861911, a BACE Inhibitor in Single‐ and Multiple‐Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration‐QTc Analysis. (5th March 2018)

3. O1‐10‐05: Pharmacodynamics of the Oral Bace Inhibitor JNJ‐54861911 in Early Alzheimer's Disease. (1st July 2016)

4. P2‐001: A Pharmacodynamic Study (54861911ALZ1008) with a Bace Inhibitor, JNJ‐54861911 in Japanese Asymptomatic Subjects at Risk for Alzheimer's Dementia. (1st July 2016)

5. P2‐010: Pharmacocokinetic and Pharmacodynamic Study (54861911ALZ1006) with a Bace Inhibitor, JNJ‐54861911, in Healthy Elderly Japanese Subjects. (1st July 2016)

6. P2‐011: Pharmacokinetic/Pharmacodynamic Modeling of CSF AB1‐40 Reduction in an Early Alzheimer's Disease Study of JNJ‐54861911, an Oral Bace1 Inhibitor. (1st July 2016)

7. Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ‐54861911, a potent oral BACE inhibitor. Issue 3 (24th August 2016)